Sunshine Heart Announces Collaboration With Minnesota-Based Minnetronix For Its C-Pulse® Fully Implantable System

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EDEN PRAIRIE, Minn., Aug. 12, 2013 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) announced today a collaboration with St. Paul-based Minnetronix® for a transcutaneous energy transfer (“TET”) system to power the Company’s fully-implantable C-Pulse device under development. Minnetronix is a leader in med-device engineering, providing design and manufacturing support for many of the world’s largest medtech companies.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC